Cell proliferation assay revealed that mitoxantrone-liposomes exhibited a significantly higher therapeutic effect in FLT3-ITD AML cell lines than mitoxantrone (Fig. 1a-e). This evidence concerns the gene FLT3 and acute myeloid leukemia.